These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36468313)
1. Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle? Loh WJ; Watts GF Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):94-102. PubMed ID: 36468313 [TBL] [Abstract][Full Text] [Related]
2. Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations. Ward NC; Watts GF; Bishop W; Colquhoun D; Hamilton-Craig C; Hare DL; Kangaharan N; Kostner KM; Kritharides L; O'Brien R; Mori TA; Nestel PJ; Nicholls SJ; Psaltis PJ; Raffoul N; White HD; Sullivan DR Heart Lung Circ; 2023 Mar; 32(3):287-296. PubMed ID: 36707360 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives. Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Kronenberg F; Mora S; Stroes ESG; Ference BA; Arsenault BJ; Berglund L; Dweck MR; Koschinsky M; Lambert G; Mach F; McNeal CJ; Moriarty PM; Natarajan P; Nordestgaard BG; Parhofer KG; Virani SS; von Eckardstein A; Watts GF; Stock JK; Ray KK; Tokgözoğlu LS; Catapano AL Eur Heart J; 2022 Oct; 43(39):3925-3946. PubMed ID: 36036785 [TBL] [Abstract][Full Text] [Related]
5. Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a). Chakraborty A; Pang J; Chan DC; Ellis KL; Hooper AJ; Bell DA; Burnett JR; Moses EK; Watts GF Atherosclerosis; 2022 May; 349():219-226. PubMed ID: 34862044 [TBL] [Abstract][Full Text] [Related]
6. To test, or not to test: that is the question for the future of lipoprotein(a). Ellis KL; Chakraborty A; Moses EK; Watts GF Expert Rev Cardiovasc Ther; 2019 Apr; 17(4):241-250. PubMed ID: 30916582 [TBL] [Abstract][Full Text] [Related]
7. All we need to know about lipoprotein(a). Bess C; Mehta A; Joshi PH Prog Cardiovasc Dis; 2024; 84():27-33. PubMed ID: 38759878 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a): a Case for Universal Screening in Youth. Alankar A; Brar PC; Kohn B Curr Atheroscler Rep; 2023 Aug; 25(8):487-493. PubMed ID: 37405555 [TBL] [Abstract][Full Text] [Related]
9. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia. Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097 [TBL] [Abstract][Full Text] [Related]
10. Consensus and guidelines on lipoprotein(a) - seeing the forest through the trees. Kronenberg F; Mora S; Stroes ESG Curr Opin Lipidol; 2022 Dec; 33(6):342-352. PubMed ID: 36251423 [TBL] [Abstract][Full Text] [Related]
11. Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care. Loh WJ; Chan DC; Mata P; Watts GF Front Genet; 2022; 13():905941. PubMed ID: 35571022 [TBL] [Abstract][Full Text] [Related]
12. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease. Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494 [TBL] [Abstract][Full Text] [Related]